Exosome-derived miR-25-3p and miR-92a-3p stimulate liposarcoma progression

Despite the development of combined modality treatments against liposarcoma (LPS) in recent years, a significant proportion of patients respond only modestly to such approaches, possibly contributing to local or distant recurrence. Early detection of recurrent or metastatic disease could improve pat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Res
Asıl Yazarlar: Casadei, Lucia, Calore, Federica, Creighton, Chad J., Guescini, Michele, Batte, Kara, Iwenofu, O. Hans, Zewdu, Abeba, Braggio, Danielle A., Lynn Bill, Kate, Fadda, Paolo, Lovat, Francesca, Lopez, Gonzalo, Gasparini, Pierluigi, Chen, James L., Kladney, Raleigh D., Leone, Gustavo, Lev, Dina, Croce, Carlo M., Pollock, Raphael E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033276/
https://ncbi.nlm.nih.gov/pubmed/28588009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-2984
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller